Ophthalmology guidance looms but industry still has no endpoints to focus on
This article was originally published in Scrip
Executive Summary
The European Medicines Agency is edging closer to producing the first ever guidance for developing ophthalmology drugs after a two day meeting with industry, healthcare professionals and patients on 27-28 October. Nevertheless, while the agency wanted more discussions and research on various topics, the industry highlighted the need for advice. At the meeting this led to a "chicken and egg frustration," according to Mark Kemp, a Datamonitor analyst who attended the event.